12 | $IMV 66% v24,4M c3.64 f8,2M H4.43 gap chop then | znewcar1 | 12/15/2022 11:04:03 PM |
11 | IMV 31% v3,5M c.7503 f82,4M H1.04 ML=LL.455 its | znewcar1 | 08/12/2022 4:34:52 PM |
10 | IMV - Friday Rundown, Monday Expectations | J L | 08/20/2021 6:31:45 PM |
9 | IMV - Report | J L | 08/01/2021 10:20:00 PM |
8 | IMV - Update | J L | 07/27/2021 1:50:02 AM |
7 | IMV 25% v61,4M c2.05 f82M H3 | znewcar1 | 07/26/2021 6:24:53 PM |
5 | IMV - MAJOR BUY ALERT | J L | 07/23/2021 7:59:08 PM |
4 | IMV 54% v62,0M c4.63 f61,7M preMH9.5 | znewcar1 | 07/14/2020 8:27:31 PM |
3 | Latest Immuno Vaccine Inc (IMMVF) Headlines | Stock_Tracker | 03/10/2014 6:18:39 AM |
2 | IMMVF 1.129 Stock Charts $IMMVF 1 Month Chart | chartguy89 | 03/07/2014 10:41:55 PM |
1 | IMMVF Stock Charts Last: -0.02 Thursday, February | chartguy89 | 02/27/2014 2:31:39 AM |
Recent Articles
- Dogecoin's Market Struggles Amid ETF Launch Challenges
- Understanding Tolebrutinib's Regulatory Journey in MS Treatment
- Exploring Corbion's Recent Share Buyback Developments
- Ipsen Launches Phase III for Groundbreaking IPN10200 in Aesthetics
- Idorsia Expands Global Presence with QUVIVIQ Launch in China
- Efficacy of Roche's Giredestrant in Advanced Breast Cancer
- Prosafe SE Reports Strong Fleet Performance and Outlook
- IPC Announces Strategic Move to Strengthen Bond Presence
- IPC Plans to Hold Fixed Income Investor Meetings to Refinance Bonds
- Sanofi's Tolebrutinib Update: FDA Review Extended for MS Treatment
- International Petroleum Corporation Plans New Bond Issuance
- Razor Labs and Process Automation Join Forces for AI Advancement
- Apple's iPhone 17 Demand Booms as Price Target Reaches New Heights
- Elon Musk and Trump Meet: Implications for Tesla and SpaceX
- Revolutionizing Travel Payments with One Source Orchestration
- Razor Labs and Process Automation Team Up for AI in Mining
- Innovative Consortium Targets Climate-Resilient Food Production
- IP Excellera's New Office Makes Strategic Mark in Abu Dhabi
- Sanofi and Regeneron: Advancements in CSU Treatment with Dupixent
- Sanofi and Regeneron’s Dupixent Receives Positive CHMP Opinion
- VT Markets Celebrates Second Year Partnership with Newcastle
- Regeneron and Sanofi Achieve Milestone with Dupixent's EU Progress
- Exciting Developments: FDA Approves LBL-047 for Autoimmune Disease
- Discovering Anhui: A Blend of Innovation and Heritage
- Bolivia's Inflation Sparks Adoption of USDT by Major Auto Brands
- Revolutionizing GRC: Discover Hyperproof AI for Growth
- Revolutionizing Fintech: The New Age of Payments and AI
- Recent Developments in CEA Industries and Its Road Ahead
- Reed Hastings Supports Trump's H-1B Proposal: Key Insights
- Concerns Over Trump's $350 Billion Investment Proposal
- Quantum Computing Inc. Secures $500 Million Through Private Placement
- SEMI Responds to Recent U.S. H1-B Visa Policy Changes
- Shiba Inu Developer Reacts to $4 Million Security Breach
- Quantum Computing Inc. Secures $500M Funding to Advance Growth
- Blue Origin Achieves Milestone Launch as Bezos and Musk React
- Market Analysis: Bitcoin and Ethereum Struggle Amid Fear
- Tronox Holdings Investors Urged to Act Before Critical Deadline
- Exploring the Global Impact of Dehua International Porcelain Culture
- Bybit Introduces ASTER Listing and Rewards Campaign
- AusperBio Secures $63 Million to Propel Hepatitis B Therapies
- Eye Level Math Olympiad 2025: Global Registration Now Open
- Important Legal Steps for LifeMD, Inc. Investors to Consider
- Revolutionizing Weight Loss: ASC47 and Semaglutide Study Results
- Faraday Future Invests $41 Million in Qualigen for Growth
- Faraday Future's $41 Million Investment to Boost Crypto Ambitions
- WuXi AppTec Announces Significant Dividend Distribution Plan
- Your Guide to Expanding into the Lucrative Asia-Pacific Market
- 3 Ways to Prepare for a Life Insurance Medical Exam In 2025
- Investors of RCI Hospitality Holdings Urged to Act Quickly
- Important Class Action for Lantheus Holdings Investors to Note